Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Richard J Bertz
The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor
Antiviral Therapy
Infectious Diseases
Pharmacology
Related publications
Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib
Journal of Clinical Pharmacology
Pharmacology
Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Evacetrapib
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Synthesis of HCV Protease Inhibitor MK-6325
Synfacts
Physical Properties and Biological Activity of Some Novel HCV NS3 Protease Inhibitors
Egyptian Journal of Physics
Influence of Mild and Moderate Hepatic Impairment on Axitinib Pharmacokinetics
Investigational New Drugs
Oncology
Pharmacology
Correlation Between Efficacy of Daclatasvir/Asunaprevir Combination Therapy and HCV NS3/NS5A Resistance-Associated Variants Detected by the PCR-Invader Assay
Acta Hepatologica Japonica
Hepatology
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Itacitinib
Journal of Clinical Pharmacology
Pharmacology
Effect of Famotidine on the Pharmacokinetics of Apixaban, an Oral Direct Factor Xa Inhibitor
Clinical Pharmacology: Advances and Applications
Pharmacology
